WallStreetZenWallStreetZen

NASDAQ: OPGN
Opgen Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

OPGN past revenue growth

How has OPGN's revenue growth performed historically?
Company
-22.68%
Industry
5.89%
Market
13.96%
OPGN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
OPGN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
OPGN's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

OPGN earnings and revenue history

Current Revenue
$3.1M
Current Earnings
-$36.2M
Current Profit Margin
-1,187%

OPGN Return on Equity

Current Company
-249.5%
Current Industry
-181%
Current Market
30.8%
OPGN's Return on Equity (-249.5%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when OPGN announces earnings.

OPGN Return on Assets

Current Company
-108%
Current Industry
5.6%
OPGN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

OPGN Return on Capital Employed

Current Company
-188.04%
Current Industry
9.9%
OPGN's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

OPGN vs Diagnostic & Research Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
OPGN$3.05M-$32.13M-$36.22M-1.47%N/A
HTGM$6.21M-$18.48M-$20.15M-18.75%N/A
VRAX$5.76k-$2.59M-$2.60M-94.76%N/A
MOTS$628.00k-$16.19M-$18.17M+120.68%N/A
TTOO$17.15M-$55.25M-$63.80M+23.22%N/A
View Top Diagnostic & Research Stocks

Opgen Earnings & Revenue FAQ

What were OPGN's earnings last quarter?

On Invalid Date, Opgen (NASDAQ: OPGN) reported Q1 2023 earnings per share (EPS) of -$1.25, up 57.34% year over year. Total Opgen earnings for the quarter were -$5.74 million. In the same quarter last year, Opgen's earnings per share (EPS) was -$2.93.

If you're new to stock investing, here's how to buy Opgen stock.

What was OPGN's earnings growth in the past year?

As of Q2 2023, Opgen's earnings has grown year over year. Opgen's earnings in the past year totalled -$36.22 million.

What was OPGN's revenue last quarter?

On Invalid Date, Opgen (NASDAQ: OPGN) reported Q1 2023 revenue of $913.44 thousand up 94.46% year over year. In the same quarter last year, Opgen's revenue was $469.75 thousand.

What was OPGN's revenue growth in the past year?

As of Q2 2023, Opgen's revenue has grown -22.68% year over year. This is 28.57 percentage points lower than the US Diagnostics & Research industry revenue growth rate of 5.89%. Opgen's revenue in the past year totalled $3.05 million.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.